Sampson, A. K., Irvine, J. C., Shihata, W. A., Dragoljevic, D., Lumsden, N., Huet, O., . . . Chin‐Dusting, J. P. F. (2015). Compound 21, a selective agonist of angiotensin AT(2) receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo. Br J Pharmacol.
Citação norma ChicagoSampson, Amanda K., et al. "Compound 21, a Selective Agonist of Angiotensin AT(2) Receptors, Prevents Endothelial Inflammation and Leukocyte Adhesion in Vitro and in Vivo." Br J Pharmacol 2015.
Citação norma MLASampson, Amanda K., et al. "Compound 21, a Selective Agonist of Angiotensin AT(2) Receptors, Prevents Endothelial Inflammation and Leukocyte Adhesion in Vitro and in Vivo." Br J Pharmacol 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.